English | Español
Press release submission | Mar 7, 2019

ALLERGAN, PLC: FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity
Press release submission | Mar 7, 2019

ARIZONA PAIN TREATMENT CENTERS: APTC and Dr. Nasser Help Patients Affected by the Closure of Laser Spine Institute
Press release submission | Feb 27, 2019

INNOVENT BIOLOGICS, INC.: First Patient Dosed in a Clinical Trial of Tyvyt® (Sintilimab injection) in Combination with IBI305 as First Line Treatment for Patients with Advanced Hepatocellular Carcinoma
Press release submission | Feb 27, 2019

KAISER PERMANENTE: Improves Emergency Care for Patients With Chest Pain
Carrie Salls | Feb 25, 2019

North Carolina citizens express concerns over water, air quality and link to increased incidence of disease due to hog farming
Press release submission | Feb 21, 2019

AIVITA BIOMEDICAL, INC.: Completes Treatment of First Patient in Phase 2 Ovarian Cancer Trial
Press release submission | Feb 21, 2019

VRHEALTH: Breast Cancer Patients Cut Hot Flashes and Night Sweats by Half with VR-AI Therapy from VRHealth, Report Finds

Press release submission | Feb 14, 2019

TROVAGENE, INC.: Presents Update on Phase 2 Study of Onvansertib in Combination with Zytiga in Patients with mCRPC at ASCO-GU Conference

Trending
+ Pharmaceuticals
Patient Daily | Oct 30, 2025

Baylor St. Luke's receives GammaTile Center of Excellence designation for brain tumor care
Patient Daily | Nov 5, 2025

Riley Gaines on 340B program: ‘Blue states are using taxpayer dollars to fund unregulated child mutilation procedures’
+ Pharmaceuticals
Patient Daily | Nov 3, 2025

Patient groups urge Congress to renew enhanced premium tax credits before open enrollment
Patient Daily | Nov 4, 2025

Philadelphia-based cardiologist: '340b is an absolute disaster that does next to nothing to help poor patients'